Drug Discovery and Development Industry Market Research & Statistics

 
  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
3 votes
Share

 

Global Drug Discovery and Development Industry

 

The global drug discovery and development industry involves the discovery and design of drugs through laboratory testing to treat disease and infection. With costs running high and few drugs making it to the market, drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.

 

One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process. The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015, according to Business Insights. Meanwhile, the global drug discovery technologies market is expected to be worth more than $32 billion by 2012, growing at an annual compound rate in excess of 8%.

 

The industry requires heavy investment with no guarantee of results, including under 1% of discoveries going on to be approved by the US Food and Drug Administration. The process itself can take between 12 and 20 years, and cost over the $1.2 billion mark, reports the Alfred Mann Foundation for Biomedical Engineering.

 

Key Drug Launches (2009 - 2013)

 

Disease area Launched Upcoming
Arrhythmia Brinavess™ (vernakalant)  
  Multaq® (dronedarone)  
Autoimmune Simponi® (golimumab) tofacitinib (JAK inhibitor)
  Stelara™ (ustekinumab)  
Diabetes Nesina® (alogliptin, DPPIV) Bydureon™ (exenatide,GLP-1)
  Onglyza™ (saxagliptin, DPPIV) canagliflozin (SGLT2)
  Victoza® (liraglutide, GLP-1) dapagliflozin (SGLT2)
    lixisenatide (GLP-1)
    Tradjenta™ (linagliptin, DPPIV)
Hepatitis C   Victrelis™ (boceprevir, NS3-4A PI)
    Incivek (telaprevir, NS3-4A PI)
Lupus Benlysta® (belimumab)  
Melanoma Yervoy™ (ipilimumab) vemurafenib
Multiple sclerosis Ampyra® (fampiridine, (oral) laquinimod (oral)
  Gilenya® (fingolimod, (oral) ocrelizumab
    teriflunomide (oral)
Osteoporosis Prolia® (denosumab)  
Thrombosis/Acute coronary syndrome Brilique™ (ticagrelor,  P2T) Eliquis (apixaban, Xa)
  Effient® (prasugrel,  Xa)  
  Pradaxa® (dabigatran  etexilate, Xa)  
Prostate cancer Firmagon® (degarelix) Zytiga™ (abiraterone acetate)
  Jevtana® (cabazitaxel)  
  Provenge® (sipuleucel-T)  

 

Source: IMS Institute for Healthcare Informatics, Apr 2011

 

 

Leading Market Segments

 

It is estimated that high throughput screening will be worth $12 billion by 2012, showing over 7% growth in the preceding five years.

 

Bioanalytical instruments have a forecast worth of $10.5 billion in 2012, demonstrating growth in excess of 9%. It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012. Business Insights estimates the electronic data capture market for clinical trials will pass the $1 billion mark in 2016 at 13% annual growth.

 

 

Process: Drug Testing and Development

 

The steps involved in drug discovery begin with the identification of targets, which are genetic or cellular chemicals that influence disease. Once the target has been isolated, the compounds that may work best on them can in turn be determined. Next, the chosen target’s capacity to act on diseased cells is observed before compounds necessary to create a drug are determined, along with the drug target’s response to the compound. In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.

 

Once a drug has been designed, it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells. The drug also undergoes toxicology testing to determine any possible harm to humans. In the clinical phase, drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug. Research compiled throughout the process is submitted to the relevant authority as the company awaits approval; this part of the process can last up to two years.

 

Contract Research Organization (CRO) Market Value (2005 - 2010) 

 

 

Industry Leaders

 

  • Charles River Laboratories International is a provider of laboratory animal services, research models and both preclinical and clinical support. In operation for over six decades, the company accompanies hospitals, government research facilities, pharmaceutical and biotechnology firms, and academic establishments around the world throughout the process of drug discovery and development. In August 2011, Charles River reached second quarter sales of $288.3 million, showing minimal year-on-year change. The company’s research models and services segment showed more than 6.5% year-on-year growth, reaching second quarter sales of $178.2 million, an increase of more than $11 million on 2010. However, second-quarter profit from preclinical services dropped more than 9% to just over $110 million. In 2005, the company saw its sales reach $1 billion.

 

  • US-based Covance is a world leader in drug development with a global presence spanning 60 countries. The company, which has over 10,000 employees, has contributed to the development of one-third of prescription drugs being sold through its partnership with biotech and pharmaceutical companies since it was established in 1997. Its yearly profits are just under $2 billion. Covance nonclinical development services include toxicology, analysis and research. In its clinical development activities, Covance has contributed to the development of half of the latest groundbreaking cancer treatments on the market.

 

 

Market Outlook

 

Growth is expected to continue in the global drug discovery and development market due to increasing demand for pharmaceuticals to treat chronic diseases such as diabetes, cardiovascular disease, mental disorders and cancer.

 

Increasing laboratory automation is speeding the process of drug discovery and development, while technological innovation is facilitating research into the molecular mechanisms of disease. Technologies giving increased support to the industry include gene expression, live cell analysis and RNA interference. In addition, technology platforms used to analyze biomarkers and compound toxicity are likely to prove key for the industry moving forward. These platforms would allow researchers to hone in on markers of disease and minimize harm derived from compounds, thereby increasing a drug’s chances of making it onto the market.

 

 

Leading Associations

 

Disease area Launched Upcoming
     
Arrhythmia Brinavess™ (vernakalant)  
  Multaq® (dronedarone)  
     
Autoimmune Simponi® (golimumab) tofacitinib (JAK inhibitor)
  Stelara™ (ustekinumab)  
     
Diabetes Nesina® (alogliptin, DPPIV) Bydureon™ (exenatide,GLP-1)
  Onglyza™ (saxagliptin, DPPIV) canagliflozin (SGLT2)
  Victoza® (liraglutide, GLP-1) dapagliflozin (SGLT2)
    lixisenatide (GLP-1)
    Tradjenta™ (linagliptin, DPPIV)
     
Hepatitis C   Victrelis™ (boceprevir, NS3-4A PI)
    Incivek (telaprevir, NS3-4A PI)
     
Lupus Benlysta® (belimumab)  
     
Melanoma Yervoy™ (ipilimumab) vemurafenib
     
Multiple sclerosis Ampyra® (fampiridine, (oral) laquinimod (oral)
  Gilenya® (fingolimod, (oral) ocrelizumab
    teriflunomide (oral)
     
Osteoporosis Prolia® (denosumab)  
     
Thrombosis/Acute coronary syndrome Brilique™ (ticagrelor,  P2T) Eliquis (apixaban, Xa)
  Effient® (prasugrel,  Xa)  
  Pradaxa® (dabigatran  etexilate, Xa)  
     
Prostate cancer Firmagon® (degarelix) Zytiga™ (abiraterone acetate)
  Jevtana® (cabazitaxel)  
  Provenge® (sipuleucel-T)  
ReportLinker.com offers immediate download access to top market reports & statistics on the Drug Discovery And Development Industry from trusted sources.
1-10 of about 200 reports

Global Drug Discovery And Development market shares

  • January 2013
    7 pages
  • Drug Discovery  

  • World  

View report >

Drug Discovery And Development Market Forecast in the US

  • March 2014
    7 pages
  • Drug Discovery  

    Clinical Resear  

    Clinical Trial  

  • United States  

View report >

Drug Discovery And Development Industry in Europe Forecast

  • January 2014
    6 pages
  • Drug Discovery  

    Pathology  

  • Europe  

    World  

View report >

Drug Discovery And Development Industry in the UK

  • January 2014
    25 pages
  • Drug Discovery  

  • United Kingdom  

View report >

Drug Discovery And Development market shares in New Zealand

  • January 2013
    13 pages
  • Drug Discovery  

    Drug Developmen  

    Drug Discovery  

  • New Zealand  

View report >

Drug Discovery And Development Industry in the US Forecast

  • December 2014
    3 pages
  • Drug Discovery  

    Clinical Trial  

  • United States  

View report >

Bioinformatics Industry in India

  • December 2014
    33 pages
  • Biotech  

    Bioinformatics  

  • India  

    Asia  

    United Kingdom  

View report >

Drug Discovery And Development Industry

  • November 2014
    13 pages
  • Drug Discovery  

    Clinical Trial  

  • Africa  

    Asia  

    United Kingdom  

View report >

Clinical Research Industry

  • September 2014
    81 pages
  • Clinical Resear  

    Clinical Trial  

View report >

Search in Drug Discovery And Development Industry (About 200 reports)
Topics under Drug Discovery and Development

Parent industry:  Pharmaceutical

Related industries: Drug and Medication, Drug Delivery Technology, Generic Drug, Over-The-Counter Drug, Pathology, Pharmacies and Drug Stores, Prescription Drug, Therapy, Vitamin and Supplement

About 3 300 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 3 124)

Biologicals in Oncology Drug Pipeline Update 2015

Biologicals in Oncology Drug Pipeline Update 2015

  • $ 3 749
  • Industry report
  • January 2015
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 980 companies plus partners developing 1676 biological ...

Biologicals In Oncology: Drug Pathway Analyzer 2015

January 2015 $ 3 675

2015 Market Research Report On Global Lc-ms Instrument ...

January 2015 $ 2 600

Global Cro Market 2015-2019

December 2014 $ 2 500

Pancreatitis Global Clinical Trials Review, H2, 2014

December 2014 $ 2 500

Mycoses Global Clinical Trials Review, H2, 2014

December 2014 $ 2 500

Nosocomial Infections Global Clinical Trials Review, H2 ...

December 2014 $ 2 500

Orthomyxoviridae Infections Global Clinical Trials Revi ...

December 2014 $ 2 500

Pediculosis (head Lice Infestation) Global Clinical Tri ...

December 2014 $ 2 500

Pneumococcal Meningitis Global Clinical Trials Review, ...

December 2014 $ 2 500


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.